CCCCNasdaq United States
Market cap
$412.416 M
$3.73 +2.47%
Close of 7 Aug 2026
Revenue
$35.9M
#2842 by revenue
Earnings
-$105.0M
Loss-making
Shares outstanding
110,567,222
Latest filing cover page
P/E ratio
—
Cap ÷ net income
Where these numbers come from
Share counts and financials for C4 Therapeutics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.